ISSN: 1017-6616 e-ISSN: 2149-8059
Home Contact Login / Sign up
-Türkçe -English
header logo
header logo
  • Home
  • Aim and Scope
  • Guide for Authors
  • Editorial Boards
  • Current Issue
  • Archive
  • Submit Article
  • Contact Us
Home Aim and Scope Guide for Authors Editorial Boards Current Issue Archive Submit Article Contact Us
kapak cover
Vol:41 Issue:1 Year:2025
Current Issue Archive Ahead of Print Copyright Notification Review Process Editorial Boards Indexing Payment Policy Archiving and Data Sharing Policy Open Access Policy Reviewer and Editor Guidelines Logo Design and Story Ethical Principles and Publication Policy Article Submission Files Contact

Search Results

PROGNOSTIC SIGNIFICANCE OF P53 ANTIGEN IN MALIGNANT MELANOMA AND NEVÜS

MUSTAFA CİHAT AVUNDUK, ŞAKİR TAVLI

 PDF  Send an Email to Editor
CLEAR CELL SARCOMA OF KNEE

HARUN KÜTAHYA, ALİ GÜLEÇ, BURKAY KUTLUHAN KAÇIRA, MEHMET ALİ ACAR, RECEP GANİ GÖNCÜ, MUSTAFA NAZIM KARALEZLİ

 PDF  Send an Email to Editor
ANORECIAL MALIGN MELANOMA PRIMER ANORECTAL MALIGN MELANOMA IS RARE

ÖZDEN VURAL, SALİM GÜNGÖR, DİLEK BİTİK

 PDF  Send an Email to Editor
LUNG AND MALIGNANT MELANOMA

HASAN SOLAK, S. SOLAK, N. SOLAK, İLHAMİ SOLAK, TAHİR YÜKSEK, F. ÖZKAN

 PDF  Send an Email to Editor
SKIN MALIGNANCIES OCCURRED ON UNEXPOSED AREAS

MEHMET OĞUZ YENİDÜNYA, HÜSEYİN TOL, ZEKERİYA TOSUN, MÜBİN HOŞNUTER, NEDİM SAVACI

 PDF  Send an Email to Editor
RECONSTRUCTION OF LARGE FACIAL DEFECTS WITH EXTENDED V-Y FLAP

AHMET DUYMAZ, FURKAN KARABEKMEZ, MUSTAFA KESKİN, MUSTAFA GÜÇLÜ

 PDF  Send an Email to Editor
MALIGNANT MELANOMA OF VULVA

SALİM GÜNGÖR, MEHMET CENGİZ ÇOLAKOĞLU, HAKAN KAYA, MEHMET ÇERÇİ

 PDF  Send an Email to Editor
footer logo
Selçuk Tıp Dergisi

[email protected]
ISSN: 1017-6616
e-ISSN: 2149-8059

Site content (images, text and applications) cannot be used without citing the source. This site has been prepared to provide information in the published content areas. When using the information on the site, the responsibility lies entirely with the user. By entering the site, you are deemed to have read, understood and accepted these terms.

This system was prepared by Dijider.